The Effect of Reducing the Intraocular Pressure by Using Alphagan Drops and Macular Edema in Patients With Diabetic Macular Edema
Phase of Trial: Clinical Phase Unknown
Latest Information Update: 31 Mar 2017
At a glance
- Drugs Brimonidine/timolol (Primary)
- Indications Diabetic macular oedema
- Focus Therapeutic Use
- 26 Mar 2017 Planned End Date changed from 1 Dec 2016 to 1 Jul 2018.
- 26 Mar 2017 Planned primary completion date changed from 1 Sep 2016 to 30 Mar 2018.
- 26 Mar 2017 Status changed from not yet recruiting to recruiting.